ELAVL1 and bladder transitional cell carcinoma: To confirm whether HuR translocation happens in urothelial carcinoma of the bladder, we first treated bladder cancer cells with four first-line chemotherapeutic agents, including cisplatin, oxaliplatin, doxorubicin and vincristine.